Track ResMed Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ResMed Inc. RMD Open ResMed Inc. in new tab

208.15 USD
P/E
19.45
EPS
10.38
Yield
1.14%
Safety Score
100
P/B
4.51
ROE
25.25
Beta
0.85
Target Price
270.60 USD
ResMed Inc. logo

ResMed Inc.

🧾 Earnings Recap – Q3 2026

Shares fell 3.3% post-earnings, with investor concerns likely centered on the CFO transition rather than the operational results themselves. The retirement of long-tenured CFO Brett Sandercock and the appointment of Aaron Blumer appears to have overshadowed double-digit revenue and EPS growth.

  • Q3 revenue increased 11% year over year (8% in constant currency).
  • Non-GAAP EPS grew 21% from the prior year.
  • Gross margin expanded 290 basis points year over year, and 50 basis points sequentially.
  • Longstanding CFO Brett Sandercock announced retirement; Aaron Blumer, former Exact Sciences CFO, appointed as successor.
  • Product innovation continued, with strong adoption of fabric-based masks and expansion of the AirSense 11 platform into new international markets.
📅
Loading chart...
Key Metrics
Earnings dateJuly 30, 2026
P/E19.45
EPS10.38
Book Value44.76
Price to Book4.51
Debt/Equity12.99
% Insiders0.501%
Growth
Revenue Growth0.11%
Earnings Growth0.11%
Estimates
Forward P/E16.61
Forward EPS12.15
Target Mean Price270.60
Dividend
Dividend Yield1.14%
Annual dividends2.40 USD
Ex-Div. DateMay 14, 2026
Payout22.39%
5y avg Yield0.83%

DCF Valuation

Tweak assumptions to recompute fair value for ResMed Inc. (RMD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ResMed Inc. Logo ResMed Inc. Analysis (RMD)

United States Health Care Official Website Stock

Is ResMed Inc. a good investment? ResMed Inc. (RMD) is currently trading at 208.15 USD. Market analysts have a consensus price target of 270.60 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 19.45. This valuation is generally in line with the broader market.

Earnings Schedule: ResMed Inc. is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 12.15.

For income investors, ResMed Inc. pays a dividend yield of 1.14%. With a payout ratio of 22%, the dividend appears sustainable.

Investor FAQ

Does ResMed Inc. pay a dividend?

Yes, it pays an annual dividend of 2.40 USD (1.14% yield).

What asset class is ResMed Inc.?

ResMed Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of 10.38.

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Exchange Ticker
NYQ (United States) RMD
Dividend Yield

1.14% (5y avg: 0.83%)

Annual Dividends

2.40 USD

Next ex. div date

May 14, 2026

Payout Ratio

22.39%

Historical Dividends
Year Total Dividends
2027 0.63 USD
2026 2.50 USD
2025 2.26 USD
2024 2.02 USD
2023 1.84 USD
2022 1.72 USD
2021 1.62 USD
2020 1.56 USD
2019 1.52 USD
2018 1.44 USD
2017 1.36 USD
2016 1.26 USD
2015 1.16 USD
2014 1.06 USD
2013 0.84 USD
2012 0.34 USD

Yearly aggregated dividends

Dividends

ResMed Inc.
Jun 18, 2026 Upcoming
Dividend
0.6 USD
ResMed Inc.
Mar 19, 2026 Paid
Dividend
0.6 USD
ResMed Inc.
Dec 18, 2025 Paid
Dividend
0.6 USD
ResMed Inc.
Sep 18, 2025 Paid
Dividend
0.6 USD

Historical Split Corporate Actions

Split Date Split Ratio to 1
April 3, 2000 2.000000
Oct. 3, 2005 2.000000
Aug. 31, 2010 2.000000
Nov. 17, 1998 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion